MD Anderson and Helsinn Healthcare SA enter strategic alliance to improve life of patients conducting clinical studies in cancer supportive and palliative care
Tuesday, April 26, 2016 - 07:30
in Health & Medicine
The University of Texas MD Anderson Cancer Center and Helsinn, a Swiss pharmaceutical group focused on building quality cancer care, today announced that they signed a strategic alliance on a broad, multi-years program of clinical studies in cancer supportive and palliative care.